Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Real-World Safety Outcomes and Clinical Efficacy of Ponatinib and Other Tyrosine Kinase Inhibitors Among Chronic Myeloid Leukemia Patients

NCT05743465 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05743465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05743465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Real-World Safety Outcomes and Clinical Efficacy of Ponatinib and Other Tyrosine Kinase Inhibitors Among Chronic Myeloid Leukemia Patients
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
October 6, 2021
Completion date
November 30, 2022
Enrollment
1,769 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia